BCRX

BioCryst Pharmaceuticals Stock Price

5.13
0.37 (7.77%)
5.13
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.37 7.77% 5.13 17:00:00
Open Price Low Price High Price Close Price Previous Close
4.81 4.80 5.14 5.13 4.76
Bid Price Ask Price Spread News
5.11 5.13 0.02 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12,032 3,803,628 $ 4.95 $ 18,832,804 4,538,416 1.58 - 6.43
Last Trade Time Type Quantity Stock Price Currency
16:54:22 49 $ 5.12 USD

BioCryst Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 905.78M 176.57M 164.27M $ 48.84M $ - -0.94 -6.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 63.34k 2.60%

more financials information »

BioCryst Pharmaceuticals News

Date Time Source News Article
11/20/202007:00GlobeNewswire Inc.BioCryst to Present at Upcoming Virtual Investment..
11/13/202007:02GlobeNewswire Inc.BioCryst Presents Data Showing Sustained Attack Rate..
11/13/202007:00GlobeNewswire Inc.BioCryst Presents New Data Highlighting Burden of Therapy..
11/12/202007:00GlobeNewswire Inc.BioCryst to Present Data at the 2020 ASH Annual Meeting
11/05/202007:12Edgar (US Regulatory)Current Report Filing (8-k)
11/05/202007:00GlobeNewswire Inc.BioCryst Reports Third Quarter 2020 Financial Results..
11/02/202016:15GlobeNewswire Inc.BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.155.134.1154.575,008,1060.9823.61%
1 Month3.745.133.704.254,620,0501.3937.17%
3 Months3.635.133.303.894,735,8751.5041.32%
6 Months5.116.203.304.295,960,2620.020.39%
1 Year2.496.431.583.806,486,6262.64106.02%
3 Years4.689.971.384.062,984,7940.459.62%
5 Years10.1910.981.384.312,280,764-5.06-49.66%

BioCryst Pharmaceuticals Description

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Your Recent History
NASDAQ
BCRX
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201127 23:23:59